Drivdahl R H, Kutter E M
Evergreen State College, Olympia, Washington 98505.
J Bacteriol. 1990 May;172(5):2716-27. doi: 10.1128/jb.172.5.2716-2727.1990.
The alc gene product (gpalc) of bacteriophage T4 inhibits the transcription of cytosine-containing DNA in vivo. We examined its effect on transcription in vitro by comparing RNA polymerase isolated from Escherichia coli infected with either wild-type T4D+ or alc mutants. A 50 to 60% decline in RNA polymerase activity, measured on phage T7 DNA, was observed by 1 min after infection with either T4D+ or alc mutants; this did not occur when the infecting phage lacked gpalt. In the case of the T4D+ strain but not alc mutants, this was followed by a further decrease. By 5 min after infection the activity of alc mutants was 1.5 to 2.5 times greater than that of the wild type on various cytosine-containing DNA templates, whereas there was little or no difference in activity on T4 HMdC-DNA, in agreement with the in vivo specificity. Effects on transcript initiation and elongation were distinguished by using a T7 phage DNA template. Rifampin challenge, end-labeling with [gamma-32P]ATP, and selective initiation with a dinucleotide all indicate that the decreased in vitro activity of the wild-type polymerase relative to that of the alc mutants was due to inhibition of elongation, not to any difference in initiation rates. Wild-type (but not mutated) gpalc copurified with RNA polymerase on heparin agarose but not in subsequent steps. Immunoprecipitation of modified RNA polymerase also indicated that gpalc was not tightly bound to RNA polymerase intracellularly. It thus appears likely that gpalc inhibits transcript elongation on cytosine-containing DNA by interacting with actively transcribing core polymerase as a complex with the enzyme and cytosine-rich stretches of the template.
噬菌体T4的alc基因产物(gpalc)在体内可抑制含胞嘧啶DNA的转录。我们通过比较从感染野生型T4D +或alc突变体的大肠杆菌中分离出的RNA聚合酶,研究了其在体外对转录的影响。在用T4D +或alc突变体感染后1分钟,观察到以噬菌体T7 DNA为模板测量的RNA聚合酶活性下降了50%至60%;当感染的噬菌体缺乏gpalt时,这种情况不会发生。对于T4D +菌株而非alc突变体,随后活性会进一步下降。感染后5分钟,在各种含胞嘧啶的DNA模板上,alc突变体的活性比野生型高1.5至2.5倍,而在T4 HMdC-DNA上活性几乎没有差异,这与体内特异性一致。通过使用T7噬菌体DNA模板区分了对转录起始和延伸的影响。利福平挑战、用[γ-32P]ATP进行末端标记以及用二核苷酸进行选择性起始均表明,野生型聚合酶相对于alc突变体的体外活性降低是由于延伸受到抑制,而不是起始速率有任何差异。野生型(而非突变型)gpalc在肝素琼脂糖上与RNA聚合酶共纯化,但在后续步骤中没有。对修饰的RNA聚合酶进行免疫沉淀也表明,gpalc在细胞内与RNA聚合酶结合不紧密。因此,gpalc似乎可能通过与正在积极转录的核心聚合酶相互作用,作为一种与酶和富含胞嘧啶的模板区域的复合物,来抑制含胞嘧啶DNA上的转录延伸。